Skip to main content

What the FDA labels say about taking them together

Loperamide and miglustat

Miglustat's FDA label of April 20, 2023 names loperamide in its warnings and precautions section; the loperamide label PlainMeds reads does not name miglustat. The miglustat label: “Diarrhea decreased over time with continued ZAVESCA treatment, and may respond to individualized diet modification, to taking ZAVESCA between meals, and/or to anti-diarrheal medications, most commonly loperamide.”

Check it at the source: the loperamide FDA label on DailyMed (effective June 3, 2026, Aurobindo Pharma Limited); the miglustat FDA label on DailyMed (effective April 20, 2023, Actelion Pharmaceuticals US, Inc.).

What does the loperamide label say about miglustat?

Loperamide's label (effective June 3, 2026) does not name miglustat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Loperamide Hydrochloride), Aurobindo Pharma Limited, effective June 3, 2026 (SPL set 8e4004be-bf79-4631-9e38-c4e7b6726313), via openFDA; the full label on DailyMed

What does the miglustat label say about loperamide?

Miglustat label, warnings and precautions

Diarrhea decreased over time with continued ZAVESCA treatment, and may respond to individualized diet modification (e.g., reduction of sucrose, lactose and other carbohydrate intake), to taking ZAVESCA between meals, and/or to anti-diarrheal medications, most commonly loperamide.

Source: FDA drug label (Zavesca), Actelion Pharmaceuticals US, Inc., effective April 20, 2023 (SPL set 817892d1-ee12-4632-85fc-57ccdf16d7b8), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

95Loperamide generic labelers
4Miglustat generic labelers
LoperamideMiglustat
Labeled forDiarrhean/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0549 per capsule 2 mg capsulen/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?